Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study

被引:46
|
作者
Nakayama, Masaaki [1 ,2 ]
Sato, Toshinobu [3 ]
Miyazaki, Mariko
Matsushima, Masato [4 ]
Sato, Hiroshi [5 ]
Taguma, Yoshio [3 ]
Ito, Sadayoshi
机构
[1] Tohoku Univ, Grad Sch Med, Ctr Adv Integrated Renal Sci, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Fukushima Med Univ, Sch Med, Fukushima, Japan
[3] Sendai Shakaihoken Hosp, Kidney Ctr, Sendai, Miyagi, Japan
[4] Jikei Univ, Sch Med, Dept Clin Res, Tokyo, Japan
[5] Tohoku Univ, Grad Sch Pharmacol, Dept Clin Pharmacol, Sendai, Miyagi 9808574, Japan
关键词
cardiovascular disease; chronic kidney disease; hypertensive nephropathy; GENERAL JAPANESE POPULATION; GLOMERULAR-FILTRATION-RATE; MECHANISMS; DYSLIPIDEMIA; PATHOGENESIS; PROTEINURIA; CHILDREN; OUTCOMES; STRESS; STROKE;
D O I
10.1038/hr.2011.96
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
To examine the clinical significance of hypertensive nephropathy (HN) among non-diabetic chronic kidney disease (CKD) patients. The study comprised 2692 CKD patients recruited from 11 outpatient nephrology clinics; these included 1306 patients with primary renal disease (PRD), 458 patients with HN, 283 patients with diabetic nephropathy (DN) and 645 patients with other nephropathies (ONs). All patients fulfilled the criteria of CKD, with a persistent low estimated glomerular filtration rate (eGFR) <60 ml min(-1) per 1.73 m(2) or proteinuria as determined by a urine dipstick test. The risk factors for cardiovascular disease (CVD), such as ischemic heart disease, congestive heart failure and stroke; all-cause mortality; and progression to end-stage renal failure (dialysis induction) were analyzed using a Cox proportional hazards model in each group. During a mean follow-up period of 22.6 months from recruitment, 100 patients were lost to follow-up and 192 patients began chronic dialysis therapy. A total of 115 CVD events occurred (stroke in 37 cases), and 44 patients died. Regarding CVD events and death, there were significant differences in the hazard ratios (HRs) for the groups of patients with different underlying renal diseases as determined by both univariate and multivariate analysis adjusted for confounding factors including estimated glomerular filtration rate: PRD, 1.0 (reference); HN, 3.33 (95% confidence interval, 1.82-6.09); DN, 5.93 (2.80-12.52); and ON, 2.22 (1.22-4.05). However, there were no differences in the hazard ratio for dialysis induction for the groups of patients with different underlying renal diseases. HN is associated with an increased risk of CVD events and death among non-diabetic CKD patients, which highlights the clinical significance of HN. Hypertension Research (2011) 34, 1106-1110; doi:10.1038/hr.2011.96; published online 28 July 2011
引用
收藏
页码:1106 / 1110
页数:5
相关论文
共 50 条
  • [21] Cardiovascular events and death in Japanese patients with chronic kidney disease
    Tanaka, Kenichi
    Watanabe, Tsuyoshi
    Takeuchi, Ayano
    Ohashi, Yasuo
    Nitta, Kosaku
    Akizawa, Tadao
    Matsuo, Seiichi
    Imai, Enyu
    Makino, Hirofumi
    Hishida, Akira
    KIDNEY INTERNATIONAL, 2017, 91 (01) : 227 - 234
  • [22] 25-hydroxyvitamin D deficiency is associated with an increased risk of metabolic syndrome in patients with non-diabetic chronic kidney disease
    Seiki, Stephanie
    Chonchol, Michel
    Cheung, Alfred K.
    Kaufman, James S.
    Greene, Tom
    Roberts, William L.
    Smits, Gerard
    Kendrick, Jessica
    CLINICAL NEPHROLOGY, 2012, 78 (06) : 432 - 441
  • [23] Arterial Stiffness in Patients with Non-Diabetic Chronic Kidney Disease (CKD)
    Matsuda, Nami
    Takei, Takashi
    Fujiu, Ayuko
    Ogawa, Tetsuya
    Nitta, Kosaku
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2009, 16 (01) : 57 - 62
  • [24] Evaluation of Cardiovascular Status with Non-Invasive Markers in Patients with Diabetic and Non-Diabetic Chronic Kidney Disease
    Karakose, Suleyman
    Guney, Ibrahim
    TURKISH JOURNAL OF NEPHROLOGY, 2020, 29 (03): : 221 - 225
  • [25] Diabetic patients with chronic kidney disease: Non-invasive assessment of cardiovascular risk
    Piko, Nejc
    Bevc, Sebastjan
    Ekart, Robert
    Petreski, Tadej
    Vodosek Hojs, Nina
    Hojs, Radovan
    WORLD JOURNAL OF DIABETES, 2021, 12 (07) : 975 - 996
  • [26] Evidence for increased cardiovascular disease risk in patients with chronic kidney disease
    Coresh, J
    Astor, B
    Sarnak, MJ
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2004, 13 (01) : 73 - 81
  • [27] Influence of Obesity on Progression of Non-Diabetic Chronic Kidney Disease: A Retrospective Cohort Study
    Othman, Muftah
    Kawar, Bisher
    El Nahas, A. Meguid
    NEPHRON CLINICAL PRACTICE, 2009, 113 (01): : C16 - C23
  • [28] Association of anthropometric obesity measures with chronic kidney disease risk in a non-diabetic patient population
    Burton, James O.
    Gray, Laura J.
    Webb, David R.
    Davies, Melanie J.
    Khunti, Kamlesh
    Crasto, Winston
    Carr, Sue J.
    Brunskill, Nigel J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (05) : 1860 - 1866
  • [29] Delayed Gastric Emptying among Indian Patients with Non-Diabetic Chronic Kidney Disease
    Kumar, Madapathi Sampath
    Vinod, Kolar Vishwanath
    Pandit, Nandini
    Sharma, Vivek Kumar
    Dhanapathi, Halanaik
    Parameswaran, Sreejith
    INDIAN JOURNAL OF NEPHROLOGY, 2021, 31 (02) : 135 - 141
  • [30] Impact of non-invasive cardiovascular screening programs as a predictor of cardiovascular events among asymptomatic chronic kidney disease patients
    Sawai, Akihiro
    Yasuda, Yoshinari
    Suzuki, Susumu
    Ishii, Hideki
    Goto, Motomitsu
    Kato, Sawako
    Hayashi, Mutsuharu
    Maruyama, Shoichi
    Murohara, Toyoaki
    Oiso, Yutaka
    Matsuo, Seiichi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2016, 20 (03) : 416 - 424